Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 23, 2026, titled “Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.SFDA for its Goa facility with VAI classification”|SUBJECT: Press Release
Source link